ATP-Sensitive Potassium Channel Openers and Blockers in the Cardiovascular System: Physiology, Pharmacology, and Clinical Effects

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Seminars in Cardiothoracic and Vascular Anesthesia

• Publication date

  1998-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/108925329800200307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment

  1998cited by this paper
• Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.

  1997cited by this paper
• Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients.

  1997cited by this paper
• Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.

  1997cited by this paper
• ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?

  1996cited by this paper
• Acidosis-Induced Coronary Arteriolar Dilation Is Mediated by ATP-Sensitive Potassium Channels in Vascular Smooth Muscle

  1996cited by this paper
• Myocardial protection with pinacidil cardioplegia in the blood-perfused heart.

  1996cited by this paper
• Glibenclamide attenuates peaked T wave in early phase of myocardial ischemia.

  1996cited by this paper
• Phorbol-12,13-dibutyrate and pinacidil cardioplegia. Novel forms of myoprotection.

  1996cited by this paper
• Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia.

  1995cited by this paper
• Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim.

  1995cited by this paper
• Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.

  1995cited by this paper
• Early Afterdepolarization Abolished by Potassium Channel Opener in a Patient with Idiopathic Long QT Syndrome

  1995cited by this paper
• Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?

  1995cited by this paper
• Protective Effect of KATP Openers in Ischemic Rat Hearts Treated with a Potassium Cardioplegic Solution

  1995cited by this paper
• Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade.

  1995cited by this paper
• Myocardial potassium loss and cell depolarisation in ischaemia and hypoxia.

  1995cited by this paper
• Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs.

  1995cited by this paper
• The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia.

  1995cited by this paper
• Acute effects of glyburide on the regulation of peripheral blood flow in normal humans.

  1995cited by this paper
• Cold cardioplegia and the K+ channel modulator aprikalim (RP 52891): improved cardioprotection in isolated ischemic rabbit hearts.

  1994cited by this paper
• POTASSIUM CHANNEL OPENERS AND OTHER REGULATORS OF KATP CHANNELS

  1994cited by this paper
• Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker

  1994cited by this paper
• Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia.

  1994cited by this paper
• Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine.

  1994cited by this paper
• Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia.

  1994cited by this paper
• Cardioprotective actions of potassium channel openers.

  1994cited by this paper
• Cellular pharmacology of potassium channel openers in vascular smooth muscle.

  1994cited by this paper
• Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.

  1994cited by this paper
• Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis.

  1994cited by this paper
• Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts

  1994cited by this paper
• Pharmacology and Structure‐Activity Relationships for KATP Modulators: Tissue‐Selective KATP Openers

  1994cited by this paper
• Protective Effects of ATP‐Sensitive Potassium‐Channel Openers in Experimental Myocardial Ischemia

  1994cited by this paper
• Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.

  1994cited by this paper
• Effects of glibenclamide on ventricular fibrillation in non‐insulin-dependent diabetics with acute myocardial infarction

  1994cited by this paper
• Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.

  1994cited by this paper
• Glibenclamide decelerates the responses of coronary regulation in the goat.

  1994cited by this paper
• KATP channels in vascular smooth muscle.

  1994cited by this paper
• Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels.

  1993cited by this paper
• The role of ATP-sensitive potassium channels in regulating coronary microcirculation

  1993cited by this paper
• Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.

  1993cited by this paper
• Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?

  1993cited by this paper
• Immediate cell signal by bone-related peptides in human osteoclast-like cells.

  1993cited by this paper
• Metabolic and Hemodynamic Effects of Metformin and Glibenclamide in Normotensive NIDDM Patients

  1993cited by this paper
• The pharmacology of ATP-sensitive potassium channels.

  1993cited by this paper
• Potassium channel activators in vasospastic angina.

  1993cited by this paper
• Role of ATP‐Sensitive K+ Channel on ECG ST Segment Elevation During a Bout of Myocardial Ischemia A Study on Epicardial Mapping in Dogs

  1993cited by this paper
• Adenosine contributes to hypoxia-induced vasodilation through ATP-sensitive K+ channel activation.

  1993cited by this paper
• Single channel and whole‐cell K‐currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein

  1993cited by this paper
• Role of K+ATP channels in coronary vasodilation during exercise.

  1993cited by this paper
• Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.

  1993cited by this paper
• Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study.

  1992cited by this paper
• Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

  1992cited by this paper
• Nicorandil Attenuates Myocardial Dysfunction Associated with Transient Ischemia by Opening ATP-Dependent Potassium Channels

  1992cited by this paper
• Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential

  1992cited by this paper
• ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo.

  1992cited by this paper
• Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart.

  1992cited by this paper
• Glibenclamide decreases basal coronary blood flow in anesthetized dogs.

  1992cited by this paper
• Antianginal and Anti‐Ischemic Efficacy of Nicorandil in Comparison with Isosorbide‐5‐Mononitrate and Isosorbide Dinitrate: Results from Two Multicenter, Double‐Blind, Randomized Studies with Stable Coronary Heart Disease Patients

  1992cited by this paper
• Modulation of potassium channels by antiarrhythmic and antihypertensive drugs.

  1992cited by this paper
• Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.

  1992cited by this paper
• Differential Effects of Nitrovasodilators, K+‐Channel Openers, and Nicorandil on Large and Small Coronary Arteries in Conscious Dogs

  1992cited by this paper
• Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.

  1992cited by this paper
• Hemodynamic and Neurohumoral Responses to Intravenous Nicorandil in Congestive Heart Failure in Humans

  1992cited by this paper
• Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia.

  1992cited by this paper
• Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism.

  1992cited by this paper
• Adenosine triphosphate-sensitive potassium channels in the cardiovascular system.

  1991cited by this paper
• ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.

  1991cited by this paper
• Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation.

  1991cited by this paper
• Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation.

  1991cited by this paper
• Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.

  1991cited by this paper
• Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

  1991cited by this paper
• The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.

  1991cited by this paper
• Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein.

  1990cited by this paper
• Potassium channel openers and vascular smooth muscle relaxation.

  1990cited by this paper
• Ischemic preconditioning reduces infarct size in swine myocardium.

  1990cited by this paper
• Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists

  1990cited by this paper
• Pinacidil

  1990cited by this paper
• Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels.

  1990cited by this paper
• Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.

  1990cited by this paper
• Properties and functions of ATP-sensitive K-channels.

  1990cited by this paper
• Nicorandil Improves postischemic Contractile function Independently of Direct Mycardial.Effects

  1990cited by this paper
• Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels.

  1990cited by this paper
• Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

  1990cited by this paper
• Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.

  1990cited by this paper
• Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891.

  1990cited by this paper
• Effects of nicorandil on arterial and venous vessels of the forearm in systemic hypertension.

  1989cited by this paper
• Hemodynamic action of nicorandil in chronic congestive heart failure.

  1989cited by this paper
• Nicorandil, a new vasodilator drug, in patients with essential hypertension.

  1989cited by this paper
• Acute hemodynamic effects of single-dose nicorandil in coronary artery disease.

  1989cited by this paper
• Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.

  1989cited by this paper
• In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.

  1989cited by this paper
• Effects of activation of ATP-sensitive K+ channels in mammalian ventricular myocytes.

  1989cited by this paper
• Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.

  1989cited by this paper
• Coronary vasodilatory action after a single dose of nicorandil.

  1988cited by this paper
• Adenosine 5'-triphosphate-sensitive potassium channels.

  1988cited by this paper
• Effects of Nicorandil on Coronary Hemodynamics in Ischemic Heart Disease: Comparison with Nitroglycerin, Nifedipine, and Propranolol

  1987cited by this paper
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

  1986cited by this paper
• The sulphonylurea receptor may be an ATP-sensitive potassium channel.

  1985cited by this paper

• No citing papers are available for this paper.